Fleet sodium phosphate, dibasic and sodium phosphate, monobasic 7 g/118mL; 19 g/118mL Enema, 133 mL
by C.B. Fleet Company, Inc. · 133 mL in 1 BOTTLE, WITH APPLICATOR (0132-0201-42)
NDC 00132-0201-42
🏷️ FDA NDC (as labeled)
0132-0201-42
billing pads the labeler segment with a zero
This package
Also priced by: Medicaid pays $0.0229/unit — full pricing hub ↓
OTC
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
0132-0201-42
Product NDC
0132-0201
11-digit billing NDC
00132020142
NCPDP billing unit
ML — per mL (volume)
RxCUI
283100
UNII
70WT22SF4B, 3980JIH2SW
Application #
M007
SPL Set ID
c1677d70-203b-493e-88f0-815a66133f1d
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
1953-03-10
Route
RECTAL
Dosage form
ENEMA
Substance
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC
GPI-14
46109902125100
GPI class
Fleet Enema
GCN Seq No
003029
GCN
66559
HICL code
001330
Ingredient (HICL)
Sodium Phosphate,Mono-Dibasic
HIC1 code
Q
Therapeutic class — broad (HIC1)
Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code
Q3
Therapeutic class — intermediate (HIC2)
Anal-Rectal Preparations
HIC3 code
Q3S
Therapeutic class — specific (HIC3)
Laxatives, Local/Rectal
AHFS code
56:12.00.00
AHFS class
Cathartics And Laxatives
FDB label name
FLEET ENEMA
FDB brand name
Enema
Legend status
O — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 0132-0201-42 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00132-0201-42. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏭 Manufacturer & labeler
LabelerC.B. Fleet Company, Inc.
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code00132
First marketedMar 1953
Product typeHuman Otc Drug
Portfolio23 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name FLEET ENEMA Ingredient Sodium Phosphate,Mono-Dibasic
🧪 What is this product?
Fleet sodium phosphate enema is an over-the-counter rectal solution containing sodium phosphate salts (dibasic and monobasic forms). This product is marketed as an OTC monograph drug, meaning it follows an established FDA rule-book for its category rather than an individual application review. Sodium phosphates in enema form are typically used as osmotic laxatives, drawing water into the bowel to promote bowel movement and relieve constipation.
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about sodium phosphate, dibasic and sodium phosphate, monobasic?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.008 | $1.12 / 133 ml |
| Medicaid paysCMS SDUD · 12 mo | $0.0229 | $3.05 / 133 ml |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per mL) — tap or hover for the price & month
▲ Up 20% over the last 9 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Saline Laxative 7 g/133mL; 19 g/133mL 00904-6320-78 | Major | 133 ml | $0.006 | — | Availability likely | save 24% |
| Foster and Thrive Ready to Use Saline Laxative 7 g/118mL; 19 g/118mL 70677-1089-01 | McKesson | 1 bottle | $0.006 | — | Availability likely | save 24% |
| Quality Choice Laxative 7 g/118mL; 19 g/118mL 83324-0292-45 | Chain | 1 bottle | $0.006 | — | Availability likely | save 24% |
| Quality Choice Laxative 7 g/118mL; 19 g/118mL 83324-0293-90 | Chain | 2 bottles | $0.006 | — | Availability likely | save 24% |
| Sunmark Saline Single Laxative 7 g/118mL; 19 g/118mL 49348-0186-14 | Strategic | 2 bottles | $0.007 | — | FDA listed | save 22% |
| HealthMart Saline Single Laxative 7 g/118mL; 19 g/118mL 62011-0271-01 | Strategic | 1 bottle | $0.008 | — | FDA listed | save 3% |
| Leader Ready to Use Saline Laxative 7 g/118mL; 19 g/118mL 70000-0108-01 | Cardinal | 1 bottle | $0.008 | — | FDA listed | save 3% |
| Fleet 7 g/118mL; 19 g/118mLthis 00132-0201-42 | C.B. | 133 ml | $0.008 | — | Availability likely | — |
| Pedia-Lax 3.5 g/66mL; 9.5 g/66mL 00132-0202-20 | C.B. | 66 ml | $0.020 | — | Availability likely | +145% |
| Saline Laxative 7 g/118mL; 19 g/118mL 00363-0005-37 | Walgreen | 1 bottle | — | — | FDA listed | — |
| Equate Ready-to-Use Enema Laxative 7 g/118mL; 19 g/118mL 49035-0002-24 | WalMart | 6 bottles | — | — | FDA listed | — |
| Pure and Gentle Laxative 7 g/118mL; 19 g/118mL 53329-0014-11 | Medline | 1 bottle | — | — | FDA listed | — |
| Freds Saline Twin Pack Laxative 7 g/133mL; 19 g/133mL 55315-0301-01 | FRED'S | 2 bottles | — | — | FDA listed | — |
| Rexall Ready to use 4pk LAXATIVE 7 g/118mL; 19 g/118mL 55910-0999-06 | Dolgencorp, | 4 bottles | — | — | FDA listed | — |
| CVS Pharmacy 7 g/118mL; 19 g/118mL 59779-0959-11 | CVS | 1 bottle | — | — | FDA listed | — |
| NATUREPLEX Enema 19 g/133mL; 7 g/133mL 67234-0020-01 | Natureplex, | 1 bottle | — | — | FDA listed | — |
| Saline Enema 7 g/118mL; 19 g/118mL 67777-0402-02 | Dynarex | 1 bottle | — | — | FDA listed | — |
| Reflief Saline Laxative Pediatric Ready To Use 3.5 g/59mL; 9.5 g/59mL 69626-0085-07 | Leosons | 1 bottle | — | — | FDA listed | — |
| Quality Choice Single Saline Laxative 7 g/118mL; 19 g/118mL 71443-0001-06 | Alcyon | 6 bottles | — | — | FDA listed | — |
| Pro-Enema Single Saline Laxative 7 g/118mL; 19 g/118mL 71451-0001-01 | Propharma | 1 bottle | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
1953
On the market since
Mar 1953
📍
2026
Currently FDA-listed
73 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🗺️ Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 00132-0201-42, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
9.4K
Units reimbursed last 4 qtrs
5.6M
Gross reimbursed last 4 qtrs
$127.3K
Avg / prescription
$13.51
Avg / unit
$0.0229
Latest quarter Q1 2026
2.4KRx
Medicaid pays / mL
$0.0229
gross reimbursed
vs
NADAC / mL
$0.0084
acquisition cost
=
Spread
+$0.0145
+173% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
Fee-for-service · 8,357 Rx Managed care · 1,067 Rx
State Medicaid map
Units reimbursed · per 100k residents
20414,609
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
💊 Medicaid utilization by pack size
Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
Drug total (last 4 qtrs): 35,117 Rx · 21,101,609 units · $464,742 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Fleet (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 44%
Female · 56%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Per unit | Per pack | Marketing start | Status |
|---|---|---|---|---|---|
| 00132-0201-40 | 133 mL in 1 BOTTLE, WITH APPLICATOR (0132-0201-40) | $0.0095 / mL | $1.27 | 2017-05-15 | Active |
| 00132-0201-42 You're viewing this | 133 mL in 1 BOTTLE, WITH APPLICATOR (0132-0201-42) | $0.0084 / mL | $1.11 | 2017-05-15 | Active |
| 00132-0201-45 | 133 mL in 1 BOTTLE, WITH APPLICATOR (0132-0201-45) | — | — | 2017-05-15 | Active |
| 00132-0201-10 | 230 mL in 1 BOTTLE, WITH APPLICATOR (0132-0201-10) | — | — | 2004-06-25 | Discontinued by firm |
This pack has the lowest per-mL cost of the 2 priced pack sizes ($0.0084 NADAC).
This pack accounts for about 27% of this product's recent Medicaid fills; most go to the 133 ml pack. See all packs ↓
Pack size FAQ
What quantity is in NDC 00132-0201-42?
NDC 00132-0201-42 contains 133 mL — 133 ml in 1 bottle, with applicator.
What is the difference between NDC 00132-0201-42 and NDC 00132-0201-40?
Both are Fleet sodium phosphate, dibasic and sodium phosphate, monobasic 7 g/118mL; 19 g/118mL Enema — the drug itself is identical. NDC 00132-0201-42 is the 133 mL package, while NDC 00132-0201-40 is the 133 ml package. Per-mL NADAC also differs: $0.0084 here vs $0.0095 for the 133 ml pack.
What NDC number is used to bill for this package of Fleet sodium phosphate, dibasic and sodium phosphate, monobasic 7 g/118mL; 19 g/118mL Enema?
Bill NDC 00132-0201-42 — the 11-digit billing format is 00132020142. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Use for relief of occasional constipation. This product usually produces a bowel movement in 1 to 5 minutes.
⏱️ Dosage and Administration ▾
Directions Single Daily Dosage (per 24 hours) Do not use if taking another sodium phosphates product. Do not use more unless directed by a doctor. See Warnings. adults and children 12 years and over 1 bottle per day children 2 to 11 yearsuse Fleet® Pedia-Lax® Enema children under 2 yearsDO NOT USE If no urge is felt after 5 minutes of using, try to empty bowel.
Call a doctor promptly if no liquid comes out of the rectum after 30 minutes because dehydration could occur.
⚠️ Warnings ▾
Warnings Using more than one enema in 24 hours can be harmful. For rectal use only. Do not use for more than 3 days if you have kidney disease if you have heart problems if you are dehydrated when abdominal pain, nausea, or vomiting are present unless directed by a doctor Ask a doctor before using this product if you are 55 years of age or older are on a sodium-restricted diet have a sudden change in bowel habits lasting more than 2 weeks already used a laxative for more than 1 week Stop use and ask a doctor if you have rectal bleeding no bowel movement or no liquid comes out of the rectum after 30 minutes symptoms of dehydration [feeling thirsty, dizziness, vomiting, urinating less often than normal] These symptoms may indicate a serious condition.
🧪 Active Ingredient ▾
Active Ingredient (in each 118 mL delivered dose) Monobasic Sodium Phosphate 19 g................ Dibasic Sodium Phosphate 7 g........................
🧪 Inactive Ingredients ▾
Inactive Ingredients benzalkonium chloride, disodium EDTA, purified water
🎯 Purpose ▾
Purpose Saline laxative Saline laxative
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.